NCT00543439 Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII Status COMPLETED Phase PHASE3
NCT00542685 A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder Status COMPLETED Phase PHASE3
NCT00542035 A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction Status COMPLETED Phase PHASE2
NCT00542009 A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight Status COMPLETED Phase PHASE2
NCT00541606 Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes Status COMPLETED Phase NA
NCT00537615 An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT00535379 SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme Status UNKNOWN Phase PHASE2
NCT00533455 Gabapentin for the Treatment of Neuroleptic-Induced Tremor Status TERMINATED Phase PHASE3
NCT00531752 A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD). Status COMPLETED Phase PHASE2
NCT00531479 Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis Status COMPLETED Phase PHASE3
NCT00528619 A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00527397 Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes Status TERMINATED Phase PHASE3
NCT00527150 Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers Status COMPLETED Phase PHASE1
NCT00527046 Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults Status TERMINATED Phase PHASE2
NCT00525733 Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01) Status COMPLETED Phase NA